Published in J Med Chem on November 25, 1994
QSAR modeling: where have you been? Where are you going to? J Med Chem (2014) 2.08
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc (2009) 1.75
Computational methods in drug discovery. Pharmacol Rev (2013) 1.51
Diterpene cyclases and the nature of the isoprene fold. Proteins (2010) 1.41
GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des (2006) 1.36
Hierarchical QSAR technology based on the Simplex representation of molecular structure. J Comput Aided Mol Des (2008) 1.34
Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorg Med Chem (2004) 1.34
Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. J Med Chem (2006) 1.27
1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets. Curr Med Chem (2009) 1.19
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation. J Med Chem (2008) 1.18
Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS Chem Neurosci (2010) 1.16
Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor. J Comput Chem (2010) 1.13
Structure-activity relationships for a new family of sulfonylurea herbicides. J Comput Aided Mol Des (2005) 1.13
3D-QSAR illusions. J Comput Aided Mol Des (2005) 1.00
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem (2009) 0.99
Molecular docking and 3D-QSAR studies on triazolinone and pyridazinone, non-nucleoside inhibitor of HIV-1 reverse transcriptase. J Mol Model (2009) 0.98
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des (2011) 0.97
Recent advances in fragment-based QSAR and multi-dimensional QSAR methods. Int J Mol Sci (2010) 0.96
Pushing the boundaries of 3D-QSAR. J Comput Aided Mol Des (2007) 0.96
Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP. Eur J Med Chem (2009) 0.94
In silico QSAR studies of anilinoquinolines as EGFR inhibitors. J Mol Model (2009) 0.93
Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease. J Med Chem (2009) 0.92
Computer-aided drug design: the next 20 years. J Comput Aided Mol Des (2007) 0.90
A comparative molecular similarity index analysis (CoMSIA) study identifies an HLA-A2 binding supermotif. J Comput Aided Mol Des (2003) 0.90
Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods. Int J Mol Sci (2011) 0.90
Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents. Bioorg Med Chem (2008) 0.90
Development of multiple QSAR models for consensus predictions and unified mechanistic interpretations of the free-radical scavenging activities of chromone derivatives. J Mol Model (2011) 0.89
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR. J Comput Aided Mol Des (2006) 0.89
3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. J Comput Aided Mol Des (2003) 0.88
Classification of auxin plant hormones by interaction property similarity indices. J Comput Aided Mol Des (1998) 0.88
Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors. J Mol Model (2011) 0.88
A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors. Int J Mol Sci (2015) 0.87
A ligand's-eye view of protein binding. J Comput Aided Mol Des (2008) 0.86
QMOD: physically meaningful QSAR. J Comput Aided Mol Des (2010) 0.86
Ligand binding to domain-3 of human serum albumin: a chemometric analysis. J Comput Aided Mol Des (2003) 0.86
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists. J Mol Model (2009) 0.85
QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR. SAR QSAR Environ Res (2011) 0.85
Comparative residue interaction analysis (CoRIA): a 3D-QSAR approach to explore the binding contributions of active site residues with ligands. J Comput Aided Mol Des (2006) 0.85
Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment. Int J Mol Sci (2011) 0.85
Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands. J Comput Aided Mol Des (2008) 0.84
4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses. Antimicrob Agents Chemother (2011) 0.84
Software and resources for computational medicinal chemistry. Future Med Chem (2011) 0.84
Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors. J Mol Model (2011) 0.83
Exploring conformational search protocols for ligand-based virtual screening and 3-D QSAR modeling. J Comput Aided Mol Des (2014) 0.83
3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment. J Mol Model (2007) 0.83
Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation. Bioorg Med Chem (2008) 0.83
How to deal with low-resolution target structures: using SAR, ensemble docking, hydropathic analysis, and 3D-QSAR to definitively map the αβ-tubulin colchicine site. J Med Chem (2013) 0.83
Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors. J Comput Aided Mol Des (2011) 0.82
Protein Alpha Shape (PAS) Dock: a new gaussian-based score function suitable for docking in homology modelled protein structures. J Comput Aided Mol Des (2006) 0.82
Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors. J Med Chem (2008) 0.82
CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors. J Mol Model (2009) 0.82
Computer-aided design of negative allosteric modulators of NMDA receptor. Dokl Biochem Biophys (2013) 0.81
BCL::EMAS--enantioselective molecular asymmetry descriptor for 3D-QSAR. Molecules (2012) 0.81
3D-QSAR study of Chk1 kinase inhibitors based on docking. J Mol Model (2012) 0.81
Isolation, biological evaluation and 3D-QSAR studies of insecticidal/narcotic sesquiterpene polyol esters. J Mol Model (2010) 0.81
Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking. J Comput Aided Mol Des (2009) 0.81
2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors. J Comput Aided Mol Des (2008) 0.81
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor. J Mol Model (2008) 0.81
Hologram and 3D-quantitative structure toxicity relationship studies of azo dyes. J Mol Model (2008) 0.80
Iterative experimental and virtual high-throughput screening identifies metabotropic glutamate receptor subtype 4 positive allosteric modulators. J Mol Model (2012) 0.80
3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors. Int J Mol Sci (2014) 0.80
Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors. Int J Mol Sci (2011) 0.80
Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity. J Mol Model (2011) 0.80
3D-QSAR study of microsomal prostaglandin E2 synthase (mPGES-1) inhibitors. J Mol Model (2007) 0.80
Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors. J Mol Model (2010) 0.80
Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors. J Chem Inf Model (2009) 0.80
3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase. Int J Mol Sci (2010) 0.80
Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics. J Mol Model (2011) 0.80
The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists. Int J Mol Sci (2012) 0.80
Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment. J Comput Aided Mol Des (2014) 0.79
Classical QSAR and comparative molecular field analyses of the host-guest interaction of organic molecules with cyclodextrins. J Comput Aided Mol Des (2000) 0.79
3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses. J Mol Model (2010) 0.79
3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach. J Comput Aided Mol Des (2007) 0.79
Integrating molecular docking, DFT and CoMFA/CoMSIA approaches for a series of naphthoquinone fused cyclic α-aminophosphonates that act as novel topoisomerase II inhibitors. J Mol Model (2010) 0.79
3D-QSAR and docking studies of flavonoids as potent Escherichia coli inhibitors. Sci Rep (2016) 0.79
Structural determinants of CX-4945 derivatives as protein kinase CK2 inhibitors: a computational study. Int J Mol Sci (2011) 0.79
Molecular docking and QSAR of aplyronine A and analogues: potent inhibitors of actin. J Comput Aided Mol Des (2009) 0.79
Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction. J Comput Aided Mol Des (2008) 0.79
Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010). Expert Opin Ther Pat (2011) 0.79
Pharmacophore and 3D-QSAR characterization of 6-arylquinazolin-4-amines as Cdc2-like kinase 4 (Clk4) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) inhibitors. J Chem Inf Model (2013) 0.79
3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model. Int J Mol Sci (2016) 0.79
Quantitative structure-activity relationship studies of mushroom tyrosinase inhibitors. J Comput Aided Mol Des (2008) 0.79
3D-QSAR study of c-Src kinase inhibitors based on docking. J Mol Model (2009) 0.79
The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods. J Comput Aided Mol Des (2005) 0.79
A comprehensive analysis of the thermodynamic events involved in ligand-receptor binding using CoRIA and its variants. J Comput Aided Mol Des (2008) 0.78
A comparative docking study and the design of potentially selective MMP inhibitors. J Comput Aided Mol Des (2001) 0.78
Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application. J Comput Aided Mol Des (1997) 0.78
Refinement of Catalyst hypotheses using simplex optimisation. J Comput Aided Mol Des (2000) 0.78
Evaluation of a novel molecular vibration-based descriptor (EVA) for QSAR studies: 2. Model validation using a benchmark steroid dataset. J Comput Aided Mol Des (1999) 0.78
Protein Alpha Shape Similarity Analysis (PASSA): a new method for mapping protein binding sites. Application in the design of a selective inhibitor of tyrosine kinase 2. J Comput Aided Mol Des (2002) 0.78
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Bioorg Med Chem (2011) 0.78
Quantitative Series Enrichment Analysis (QSEA): a novel procedure for 3D-QSAR analysis. J Comput Aided Mol Des (2008) 0.78
Pyrrolo[3,2-d]pyrimidine derivatives as type II kinase insert domain receptor (KDR) inhibitors: CoMFA and CoMSIA studies. Int J Mol Sci (2012) 0.78
Design of 1-arylsulfamido-2-alkylpiperazine derivatives as secreted PLA2 inhibitors. J Mol Model (2010) 0.78
Pharmacophore and molecular docking guided 3D-QSAR study of bacterial enoyl-ACP reductase (FabI) Inhibitors. Int J Mol Sci (2012) 0.78
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses. J Mol Model (2009) 0.78
CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents. Bioinformation (2008) 0.78
Structural studies of B-type Aurora kinase inhibitors using computational methods. Acta Pharmacol Sin (2010) 0.78
Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor. Int J Mol Sci (2011) 0.78
CoMFA and CoMSIA 3D-quantitative structure-activity relationship model on benzodiazepine derivatives, inhibitors of phosphodiesterase IV. J Comput Aided Mol Des (2001) 0.78
Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries. J Comput Aided Mol Des (1999) 1.17
Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. J Med Chem (1998) 1.16
A fast and efficient method to generate biologically relevant conformations. J Comput Aided Mol Des (1994) 1.08
Photoperiodic information acquired and stored in vivo is retained in vitro by a circadian oscillator, the avian pineal gland. Proc Natl Acad Sci U S A (2000) 1.02
Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors. J Comput Aided Mol Des (1994) 0.92
Initial demonstration of rhythmic Per gene expression in the hypothalamus of a non-mammalian vertebrate, the house sparrow. Neuroreport (2001) 0.85
On the prediction of binding properties of drug molecules by comparative molecular field analysis. J Med Chem (1993) 0.82
Methodological developments and strategies for a fast flexible superposition of drug-size molecules. J Comput Aided Mol Des (1999) 0.79
Nutritional assessment of hospital outpatients. Indian J Med Res (1987) 0.75
Annual change in insulin sensitivity. Horm Metab Res (2011) 0.75
[Results of nuclear medical, electroencephalographic, and angiographic examinations after brain tumor operations]. Psychiatr Neurol Med Psychol (Leipz) (1975) 0.75
[Results of nuclear medical and electroencephalographic examinations after brain tumour operation (author's transl)]. Radiol Diagn (Berl) (1974) 0.75
[Effect of Faustan (diazepam) on the EEG of epileptics]. Psychiatr Neurol Med Psychol (Leipz) (1974) 0.75